Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
The American Journal of Pathology|April 13, 2013
B7h (ICOS-L) maintains tolerance at the fetomaternal interfaceLeonardo V Riella, Shirine Dada, Lola Chabtini, et al.Cell Transplantation|October 28, 2010
The mobilization and effect of endogenous bone marrow progenitor cells in diabetic wound healingPaolo Fiorina, Giorgio Pietramaggiori, Saja S Scherer, et al.Diabetes|September 5, 2014
Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigensSonja Kleffel, Andrea Vergani, Sara Tezza, et al.Acta Diabetologica|March 27, 2015
Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged siteMoufida Ben Nasr, Andrea Vergani, James Avruch, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 30, 2009
Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetesPaolo Fiorina, Mollie Jurewicz, Andrea Augello, et al.Diabetes Care|September 13, 2013
Islet transplantation stabilizes hemostatic abnormalities and cerebral metabolism in individuals with type 1 diabetesFrancesca D'Addio, Paola Maffi, Paolo Vezzulli, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2010
Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1Paolo Fiorina, Mollie Jurewicz, Andrea Vergani, et al.Diabetes|October 21, 2011
IL-21 is an antitolerogenic cytokine of the late-phase alloimmune responseAlessandra Petrelli, Michele Carvello, Andrea Vergani, et al.Diabetes|January 15, 2013
Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejectionAndrea Vergani, Carmen Fotino, Francesca D'Addio, et al.Cell Transplantation|March 12, 2014
TIM4 Regulates the Anti-Islet Th2 Alloimmune ResponseAndrea Vergani, Francesca Gatti, Kang M Lee, et al.Pageof 4